042520 — HANS BIOMED Cashflow Statement
0.000.00%
Last trade - 00:00- KR₩154bn
- KR₩178bn
- KR₩78bn
- 58
- 24
- 22
- 23
Annual cashflow statement for HANS BIOMED, fiscal year end - September 30th, KRW millions except per share, conversion factor applied.
2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | 2023 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,511 | -18,171 | -22,126 | 4,923 | -24,092 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 3,185 | 28,194 | 2,687 | -6,915 | 21,874 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7,718 | -9,069 | -818 | -7,180 | -6,714 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 6,732 | 4,567 | -15,472 | -4,270 | -3,733 |
| Capital Expenditures | -15,740 | -7,973 | -5,208 | -4,134 | -2,067 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -17,622 | 6,843 | -15,983 | 7,301 | 5,387 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Sale of Intangible Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -33,363 | -1,130 | -21,190 | 3,167 | 3,320 |
| Financing Cash Flow Items | 1,302 | 339 | 1,204 | 864 | 1,053 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 28,498 | 61.2 | 29,738 | 1,387 | -829 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1,840 | 3,436 | -6,790 | 473 | -1,392 |